What is Dr Agarwals Eye Hospital Ltd (DRAGARWQ) share price return in the past 10 years?

Dr Agarwals Eye Hospital Ltd share price has appreciated 38.3% annually (CAGR) over the past ten years.

What is the share price of Dr Agarwals Eye Hospital Ltd (DRAGARWQ)?

Company share prices are keep on changing according to the market conditions. The current trading price of Dr Agarwals Eye Hospital Ltd (DRAGARWQ) on 02-Jul-2026 16:59:59 at 16:59 is 5105.95.

What is the P/E ratio of Dr Agarwals Eye Hospital?

The latest standalone P/E ratio of Dr Agarwals Eye Hospital as of 02-Jul-2026 is 35.20.

What is the P/B ratio of Dr Agarwals Eye Hospital Ltd (DRAGARWQ)?

The latest standalone P/B ratio of Dr Agarwals Eye Hospital Ltd (DRAGARWQ) as of 02-Jul-2026 is 7.13.

What is the 52-week high and low of Dr Agarwals Eye Hospital Ltd (DRAGARWQ)?

The 52-week high of Dr Agarwals Eye Hospital Ltd (DRAGARWQ) is Rs. 6392.00 and the 52-week low is Rs. 4231.00.

Dr Agarwals Eye Hospital Ltd (DRAGARWQ) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Dr Agarwals Eye Hospital Ltd (DRAGARWQ)
Brand: Dr Agarwals Eye Hospital

Dr Agarwals Eye Hospital Ltd (DRAGARWQ)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 526783 NSE: DRAGARWQ Hospital & Healthcare Services | Small Cap | Dr Agarwals Eye Hosp Share Price

Dr Agarwals Eye Hospital Ltd (DRAGARWQ)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 526783 NSE: DRAGARWQ Hospital & Healthcare Services | Small Cap | Dr Agarwals Eye Hosp Share Price

Key Metrics

Valuation Multiples

Market Cap

₹2,468 Cr.

Current Price

₹5,106

52-Week Low / High

₹4,231 / 6,392

TTM EPS

₹145.1

TTM Sales

₹471 Cr.

Book Value per Share

₹716.6

P/E Ratio

35.20

Higher than its 5-year historical median

Industry PE

93.2

Price to Book (P/B)

7.13

In line with its 5-year historical median

Price to Sales (P/S)

5.24

Higher than its 5-year historical median

EV/EBITDA

16.82

Higher than its 5-year historical median

Dividend Yield

0.12%

Profitability Efficiency

Return on Equity (ROE)

29.80%

Return on Capital Employed (ROCE)

33.26%

Return on Assets (ROA)

8.97%

Operating Profit Margin

30%

Net Profit Margin

13.76%

Gross Profit Margin

27.7%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

24.38%

Operating Profit Growth (1 Year)

Improving versus 3-year growth rate

29.57%

Net Profit Growth (1 Year)

Slowing versus 3-year growth rate

17.88%

Asset Quality

Promoter Holding

72.67%

Pledged shares (%) of Promoter's holding (%)

29.26%

Reserves

₹341 Cr.

Equity

₹4.8 Cr.

Face Value

₹10

All Time Low / High

₹2.10 / 7300.00

Dr Agarwals Eye Hospital stock performance

Key Ratios

Check Before You Invest

Quality

Very Good

Check detailed performance

Valuation

Somewhat Overvalued

Check Valuation charts

Price Trend

Semi Strong

Check Price chart

Q.1 Is Dr Agarwals Eye Hospital Ltd a good quality company?

Dr Agarwals Eye Hospital Ltd is a good quality company, based on a consistently good multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Dr Agarwals Eye Hospital Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Dr Agarwals Eye Hospital Ltd vs industry peers?

Dr Agarwals Eye Hospital Ltd revenue CAGR is 17.68%, compared to the industry median CAGR of 1.38%, indicating faster growth and gaining its market share.

Q.1 Promoter shareholding and pledge status of Dr Agarwals Eye Hospital Ltd?

Promoters hold 72.67% of the Dr Agarwals Eye Hospital Ltd, with 29.26% of their stake pledged, indicating high pledge risk.

Q.1 Stock return of Dr Agarwals Eye Hospital Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 41.6% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	7.7%	28.3%	31.7%	34.3%	39.9%	16.9%	42.4%	43%	38.6%	33.3%	-
Value Creation Index ⓘ	-0.5	1.0	1.3	1.5	1.9	0.2	2.0	2.1	1.8	1.4	-
Growth Parameters ⓘ
Sales ⓘ	137	149	153	170	176	140	201	268	319	397	471
Sales YoY Gr.	-	8.8%	3.2%	10.9%	3.5%	-20.5%	43.9%	33.2%	19.1%	24.4%	-
Adj EPS ⓘ	-0.1	16.2	14.5	25.3	29.3	-3	51	78.7	99	115.3	145.1
YoY Gr.	-	NA	-10.5%	74.2%	15.7%	-110.3%	NA	54.4%	25.8%	16.5%	-
BVPS (₹) ⓘ	49.8	62.6	74.6	97	119.4	116.3	166.3	241.2	334.4	446	716.6
Adj Net Profit ⓘ	-0	7.6	6.8	11.9	13.8	-1.4	24	37	46.5	54.2	70
Cash Flow from Ops. ⓘ	17.4	20.1	18.6	25.1	38.6	33.9	56.7	69.6	89.8	94.5	-
Debt/CF from Ops. ⓘ	1.8	1.2	1	1	0.5	0.6	0.6	0.6	0.6	1	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	12.6%	17.7%	25.4%	24.4%
Adj EPS ⓘ	NA	31.5%	31.3%	16.5%
BVPSⓘ	27.6%	30.2%	38.9%	33.4%
Share Price	38.3%	62.6%	54.1%	18.1%

Key Financial Parameters ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	-0.2	28.9	21.2	29.5	27.1	-2.6	36.1	38.6	34.4	29.6	25
Op. Profit Mgn % ⓘ	9	15.2	15.9	17.6	26.9	21.4	29.2	28.3	28.9	30.1	30.9
Net Profit Mgn % ⓘ	-0	5.1	4.5	7	7.8	-1	11.9	13.8	14.6	13.7	14.9
Debt to Equity ⓘ	1.3	0.8	0.5	0.5	0.3	0.4	0.4	0.4	0.3	0.5	0.2
Working Cap Days ⓘ	114	112	117	124	131	150	103	92	94	103	50
Cash Conv. Cycle ⓘ	-14	-19	-23	-22	-10	-15	-30	-32	-26	-18	11

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	137	149	153	170	176	140	201	268	319	397
Operating Expenses ⓘ +	124	126	129	140	129	110	143	192	227	278
Manufacturing Costs	29	26	27	30	31	27	35	47	58	65
Material Costs	34	35	34	38	40	33	47	61	71	90
Employee Cost	29	32	32	34	36	32	39	53	64	78
Other Costs ⓘ	32	33	36	39	22	18	23	31	35	45
Operating Profit ⓘ	12	22	24	30	47	30	59	76	92	119
Operating Profit Margin (%)	9.0%	15.0%	15.8%	17.6%	26.8%	21.3%	29.1%	28.3%	28.8%	30.0%
Other Income ⓘ +	0	2	2	2	3	2	1	2	5	6
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	5	4	3	4	9	7	7	8	8	15
Depreciation ⓘ	9	9	10	11	21	19	20	20	27	39
Profit Before Tax ⓘ	-0	11	13	17	20	6	32	49	62	71
Tax ⓘ	-1	4	7	6	6	7	8	12	16	16
Profit After Tax	0	7	7	12	14	-1	24	37	46	55
PAT Margin (%)	0.0%	4.9%	4.4%	7.0%	7.8%	-1.0%	12.0%	13.8%	14.5%	13.8%
Adjusted EPS (₹)	0.1	15.6	14.4	25.4	29.1	-3.1	51.3	78.6	98.6	116.3
Dividend Payout Ratio (%)	1,024.30%	9.60%	8.30%	5.90%	0%	0%	5.90%	3.80%	5.10%	5.20%

Valuation of Dr Agarwals Eye Hosp - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	23	29	35	46	56	55	78	113	157	210
Share Capital ⓘ	5	5	5	5	5	5	5	5	5	5
Reserves ⓘ	19	25	30	41	51	50	73	109	152	205
Debt +	24	16	10	18	13	17	27	40	44	82
Long Term Debt	18	13	5	13	8	10	21	36	44	82
Short Term Debt	6	3	5	5	5	7	6	4	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	18	14	18	15	14	18	26	27	32	30
Others Liabilities ⓘ	19	22	33	41	83	78	203	242	308	355
Total Liabilities ⓘ	84	81	96	120	166	167	333	422	541	677
Fixed Assets
Net Fixed Assets ⓘ +	34	33	36	55	94	96	214	260	316	393
Gross Block	87	37	49	78	138	158	295	365	446	562
Accumulated Depreciation	53	4	13	23	44	62	81	104	131	169
CWIP ⓘ	1	1	3	0	0	0	26	62	97	128
Investments ⓘ	0	0	0	0	0	0	0	0	0	13
Inventories	10	6	7	6	8	5	6	6	10	13
Trade Receivables	9	7	7	9	7	9	9	10	13	14
Cash Equivalents	2	3	2	5	7	22	29	28	34	12
Others Assets ⓘ	28	31	40	45	51	36	49	55	72	104
Total Assets ⓘ	84	81	96	120	166	167	333	422	541	677

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	17	20	19	25	39	34	57	70	90	94
PBT ⓘ	-0	11	13	17	20	6	32	49	62	71
Adjustment ⓘ	15	11	13	13	28	27	27	27	31	50
Changes in Working Capital ⓘ	5	1	-2	3	-3	4	6	5	10	-6
Tax Paid ⓘ	-3	-3	-5	-8	-7	-3	-9	-12	-14	-20
Cash Flow From Investing Activity ⓘ +	-17	-8	-11	-25	-17	-11	-46	-71	-70	-133
Capex	-17	-8	-11	-25	-17	-11	-46	-70	-70	-102
Net Investments	-0	-0	0	-0	0	-0	-0	-0	-1	-30
Others ⓘ	0	1	1	0	0	0	0	-0	1	0
Cash Flow From Financing Activity ⓘ +	-0	-12	-8	2	-20	-8	-4	0	-14	17
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	6	-5	-7	6	-6	2	11	20	9	37
Interest Paid ⓘ	-4	-3	-3	-3	-3	-2	-2	-2	-0	-3
Dividend Paid ⓘ	-1	-0	-1	-1	-1	-0	-0	-1	-3	-2
Others ⓘ	-2	-3	2	0	-10	-7	-13	-17	-20	-15
Net Cash Flow ⓘ	0	0	-0	2	2	15	7	-1	6	-22

Financial Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	0.16	27.78	21.02	29.55	26.91	-2.6	36.29	38.56	34.28	29.8
ROCE (%)	7.7	28.26	31.7	34.3	39.87	16.92	42.4	42.98	38.59	33.26
Asset Turnover Ratio	1.8	1.8	1.73	1.57	1.23	0.84	0.8	0.71	0.66	0.65
PAT to CFO Conversion(x)	N/A	2.86	2.71	2.08	2.79	N/A	2.38	1.89	1.96	1.71
Working Capital Days
Receivable Days	20.20	19.30	16.30	16.90	16	20.30	15.80	12.80	13.20	12.40
Inventory Days	27.10	19.70	16	14.80	15	17.20	9.90	8	9	10.60
Payable Days	184.20	167	170.60	159.40	131.50	175.90	170.20	156.80	151.40	126.30

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

39.95

0.00

55.45

29.26

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Dr Agarwals Eye Hospital Ltd FAQs

The current trading price of Dr Agarwals Eye Hosp on 02-Jul-2026 16:59 is ₹5,106.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jul-2026 the market cap of Dr Agarwals Eye Hosp stood at ₹2,467.6 Cr

The latest P/E ratio of Dr Agarwals Eye Hosp as of 01-Jul-2026 is 35.20.

The latest P/B ratio of Dr Agarwals Eye Hosp as of 01-Jul-2026 is 7.13.

The 52-week high of Dr Agarwals Eye Hosp is ₹6,392 and the 52-week low is ₹4,231.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Dr Agarwals Eye Hosp is ₹471 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Dr Agarwals Eye Hospital Ltd is a good quality company.

The key valuation ratios of Dr Agarwals Eye Hospital Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Dr Agarwals Eye Hospital Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

About Dr Agarwals Eye Hospital Ltd

Dr Agarwal’s Eye Hospital, founded in 1957 and registered in 1994 as a Company, is a leading chain of eye hospitals with predominant presence in Tamil Nadu. Under the able leadership of Dr Amar Agarwal, the company has been a pioneer and leader in the Ophthalmology market with an established market position and healthy brand recall in the eye care segment. It offers comprehensive services in the eye-care segment including Cataract, Glaucoma, Laser Correction, Cornea and Refractive, Retina, and Squint among others. The company provides comprehensive services across all major ophthalmic specialities. It offers comprehensive services in the eye-care segment including Cataract, Glaucoma, Laser Correction, Cornea and Refractive, Retina, and Squint among others. The hospital uses advanced diagnostic technology, precision surgical systems and global best practices to ensure accurate treatment outcomes. Each speciality is supported by dedicated teams trained in complex procedures and emerging innovations.

Business area of the company

Dr Agarwals Eye Hospital is primarily engaged in running, owning and managing eye care hospitals, opticals, pharmacies, etc. and related services.

Eye Treatments & Surgery

Trabeculectomy Surgery for Glaucoma
Glaucoma Shunt Surgery
Silk LASIK
Laser Trabeculoplasty for Glaucoma Treatment
YAG Peripheral Iridotomy (YAG PI)
Minimally Invasive Glaucoma Surgery (MIGS)
Robotic Cataract
Central Serous Retinopathy (CSR)
Hyperopia
Stye Eye Treatment
Refractive Surgery
Myopia
Contoura Lasik
Lasik Surgery
Flapless LASIK
Photorefractive Keratectomy (PRK)
Implantable Collamer Lens (ICL)
Eyelid & Eye Socket Correction (Oculoplasty)
Glued IOL
CAIRS Eye Surgery
Advanced Corneal Transplant (PDEK)
Pneumatic Retinopexy (PR)
Cornea Transplantation
Pinhole Pupilloplasty
Paediatric Ophthalmology
Cryopexy
Retina Injection Therapy (Anti-VEGF)
Cosmetic Eye Surgery
Dry Eye Treatment
Retinal Laser Photocoagulation
Retina Repair Surgery (Vitrectomy)
Scleral Buckle
Laser Cataract Surgery
Black Fungus Treatment & Diagnosis
Neuro Ophthalmology

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Dr Agarwals Eye Hospital Ltd (DRAGARWQ)

Dr Agarwals Eye Hospital Ltd (DRAGARWQ)

Dr Agarwals Eye Hospital stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Dr Agarwals Eye Hosp - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Dr Agarwals Eye Hospital Ltd FAQs

What is the share price of Dr Agarwals Eye Hosp?

What is the market cap of Dr Agarwals Eye Hosp?

What is the P/E ratio of Dr Agarwals Eye Hosp?

What is the P/B ratio of Dr Agarwals Eye Hosp?

What is the 52-week high and low of Dr Agarwals Eye Hosp?

What is the TTM revenue of Dr Agarwals Eye Hosp?

Is Dr Agarwals Eye Hospital Ltd a good quality company?

Is Dr Agarwals Eye Hospital Ltd undervalued or overvalued?

Is Dr Agarwals Eye Hospital Ltd a good buy now?

About Dr Agarwals Eye Hospital Ltd

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.